Autores: Vera, R. (Autor de correspondencia); Otero, M. J.; de la Pena, F. A. ; Gonzalez-Perez, C.; Penuelas, A. ; Sepulveda, J. M.; Quer, N. ; Domenech-Climent, N.; Virizuela, J. A.;
Beorlegui Murillo, Patricia; Gorgas, M. Q.
Resumen:
AimTo define recommendations that permit safe management of antineoplastic medication, minimise medication errors and improve the safety of cancer patients undergoing treatment.MethodsBy reviewing the literature and consulting the websites of various health organisations and agencies, an expert committee from the Spanish Society of Hospital Pharmacy and the Spanish Society of Medical Oncology defined a set of safe practices covering all stages of providing cancer therapy to patients. The Spanish Society of Oncology Nursing revised and endorsed the final list.ResultsIn total, 68 recommendations arranged in five sections were defined. They include issues concerning the training of health professionals, the technological resources needed, treatment planning, informing the patient and his/her family, the processes of prescribing, preparing, dispensing and administering cancer therapy (orally, parenterally or intrathecally), assessing patient adherence and treatment toxicity.ConclusionsIt is essential for healthcare establishments to implement specific measures designed to prevent medication errors, in order to ensure the safety of cancer patients treated with antineoplastic medication.
